BAIRI Digital Biology
Plasma multi-omics + AI — trusted AI in the most rigorous domain.
Capability map
Evidence
Industry
Geography
Trust features
Trusted AI for Life Science
Executive Summary
BAIRI is a biotech AI research institute applying plasma multi-omics (PPdPM) + AI to early detection and differentiation of lung cancer and tuberculosis, extending into digital biology through BAIRI-X Lab. In life science — where evidence standards are highest and tolerance for error lowest — it is the strongest proof of the depth and portability of Entrust's trusted-AI capability.
Evidence Snapshot
BAIRI multi-omics database to date
Real-World Signals
Organization
BAIRI · BAIRI-X Lab
Research
Why It Matters
If the same capability can operate in life science — explainable, auditable, clinician-in-the-loop — it proves Entrust's approach isn't domain-bound marketing.
Business Challenge
- Biological signals are high-dimensional; no single protein or metabolite explains disease
- ~95% of CT-detected pulmonary nodules are benign; single-marker sensitivity is often <70%
- Life science has near-zero tolerance for error — conclusions must be explainable and reviewable
- Knowledge must be validated, never guessed
Solution Architecture
Understand · AI engine
PPdPM profiles plasma proteins, amino acids and bile acids together; AI integrates clinical data to find patterns invisible to single markers.
Remember · Multi-omics database
Precision and generalizability improve as the sample database grows (3,000+ lung nodule, 4,000+ TB).
Govern · Clinical boundary
AI outputs a risk score; the clinician owns the diagnostic decision, with human review for high-risk cases.
Act · On-site AI Appliance
On-device inference, LIS / HIS integration, data stays inside the hospital.
Trust & Governance
- Clinician always in the decision loop: AI assists, never replaces
- Explainable AI; results reviewable and traceable
- Research-grade rigor and reproducibility
- Regulatory guardrail: diagnostic products are under development and validation, not approved medical devices; BAIRI-X Lab represents forward-looking research
Decision Provenance · Decision Trail
Each step is explainable and reviewable; the clinician owns the final judgment. Key evidence can optionally be recorded into a Trust Ledger.
Outcomes
Strategic Value
On the EBT site, BAIRI is not a product pitch — it is evidence: when trusted AI can operate in the hardest domain of all, the same capability can serve enterprises, governments and cities. Several Entrust leaders are also deeply involved in BAIRI and BAIRI-X Lab.
Next Phase
BAIRI is preparing a NMPA Class III innovative-device pathway (multi-center prospective validation, technical documentation and device-approval preparation); BAIRI-X Lab continues research in explainable AI diagnostics, virtual cell and digital biology. Diagnostic products remain under development and validation, not approved medical devices.